Statins for people at low risk of cardiovascular disease

Comment

Nicholas Wald et al. Lancet. 2012.

. 2012 Nov 24;380(9856):1818.

doi: 10.1016/S0140-6736(12)62028-5.

No abstract available

Comment in

Loss of reason.
O'Brien E. O'Brien E. Lancet. 2013 Mar 23;381(9871):996. doi: 10.1016/S0140-6736(13)60711-4. Epub 2013 Mar 22. Lancet. 2013. PMID: 23668583 No abstract available.

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
Cholesterol Treatment Trialists' (CTT) Collaborators; Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C. Cholesterol Treatment Trialists' (CTT) Collaborators, et al. Lancet. 2012 Aug 11;380(9841):581-90. doi: 10.1016/S0140-6736(12)60367-5. Epub 2012 May 17. Lancet. 2012. PMID: 22607822 Free PMC article.
Statins for all by the age of 50 years?
Ebrahim S, Casas JP. Ebrahim S, et al. Lancet. 2012 Aug 11;380(9841):545-7. doi: 10.1016/S0140-6736(12)60694-1. Epub 2012 May 17. Lancet. 2012. PMID: 22607823 No abstract available.